Related Experiment Video

Updated: Jun 23, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C

Sarah Maylin1, Michelle Martinot-Peignoux, Rami Moucari

  • 1Université Paris VII, Hôpital Beaujon, Clichy, France.

Gastroenterology
|July 3, 2008
PubMed

Insights

Sustained virologic response (SVR) in chronic hepatitis C patients is durable and leads to liver fibrosis improvement. Residual hepatitis C virus (HCV) RNA was rarely detected in liver tissue, suggesting SVR may indicate HCV eradication.

Area of Science:

  • Hepatology
  • Virology
  • Gastroenterology

Background:

  • Chronic hepatitis C virus (HCV) infection poses a risk for liver disease progression.
  • The long-term durability and potential eradication of HCV following sustained virologic response (SVR) remain subjects of investigation.

Purpose of the Study:

  • To assess the durability of SVR in patients with chronic hepatitis C.
  • To determine the presence of residual HCV RNA in serum, liver, and PBMCs post-SVR.
  • To evaluate the impact of SVR on liver fibrosis and cirrhosis.

Main Methods:

  • Long-term follow-up of 344 chronic hepatitis C patients achieving SVR after interferon-based therapy.
  • Assessment of HCV RNA in serum, liver tissue, and PBMCs using transcription-mediated amplification.
  • Evaluation of liver fibrosis using the METAVIR score and analysis of liver biopsy specimens.

Main Results:

  • SVR was durable up to 18 years, with undetectable serum HCV RNA in all patients.
  • Residual HCV RNA was detected in 1.7% of liver specimens but not in PBMCs.
  • Liver fibrosis improved or stabilized in 88% of patients, with 64% showing cirrhosis regression.

Conclusions:

  • SVR in chronic hepatitis C is a durable outcome associated with significant liver fibrosis improvement and cirrhosis regression.
  • The rare detection of residual HCV RNA in liver tissue suggests that SVR may be considered indicative of HCV eradication.
  • Long-term SVR offers substantial benefits for patients with chronic hepatitis C.
Abstract

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...